View Item 

Show simple item record

Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men

dc.contributor.authorOesterling, Joseph E.en_US
dc.contributor.authorKumamoto, Y.en_US
dc.contributor.authorTsukamoto, T.en_US
dc.contributor.authorGirman, Cynthia J.en_US
dc.contributor.authorGuess, H. A.en_US
dc.contributor.authorMasumori, N.en_US
dc.contributor.authorJacobsen, Steven J.en_US
dc.contributor.authorLieber, Michael M.en_US
dc.date.accessioned2010-06-01T19:18:18Z
dc.date.available2010-06-01T19:18:18Z
dc.date.issued1995-03en_US
dc.identifier.citationOesterling, J.E.; Kumamoto, Y.; Tsukamoto, T.; Girman, C.J.; Guess, H.A.; Masumori, N.; Jacobsen, S.J.; Lieber, M.M. (1995). "Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men." British Journal of Urology 75(3): 347-353. <http://hdl.handle.net/2027.42/72449>en_US
dc.identifier.issn0007-1331en_US
dc.identifier.issn1464-410Xen_US
dc.identifier.urihttps://hdl.handle.net/2027.42/72449
dc.format.extent669529 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights1995 BJU International Companyen_US
dc.subject.otherProstate-specific Antigenen_US
dc.subject.otherAge-specific Reference Rangesen_US
dc.subject.otherJapaneseen_US
dc.subject.otherWhite Menen_US
dc.subject.otherRaceen_US
dc.titleSerum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white menen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDivision of Urology and the Michigan Prostate Center, University of Michigan, Ann Arbor, Michigan, USAen_US
dc.contributor.affiliationotherDepartment of Urology, Sapporo Medical College, Sapporo, Japanen_US
dc.contributor.affiliationotherMerck Research Laboratories, Blue Bell, Pennsylvania, USAen_US
dc.contributor.affiliationotherDepartment of Health Sciences Research, Section of Clinical Epidemiologyen_US
dc.contributor.affiliationotherDepartment of Urology, Mayo Clinic and Foundation, Rochester, Minnesota, USAen_US
dc.identifier.pmid7537604en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/72449/1/j.1464-410X.1995.tb07347.x.pdf
dc.identifier.doi10.1111/j.1464-410X.1995.tb07347.xen_US
dc.identifier.sourceBritish Journal of Urologyen_US
dc.identifier.citedreferenceOesterling JE. Prostate specific antigen:a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991; 145: 907 23.en_US
dc.identifier.citedreferenceBenson MC, Whang IS, Pantuck A et al. Prostate specific antigen density:a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 1992; 147: 815 6.en_US
dc.identifier.citedreferenceBenson MC, Whang IS, Olsson CA, McMahon DJ, Cooner WH. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J Urol 1992; 147: 817 21.en_US
dc.identifier.citedreferenceCarter HB, Pearson JD, Metter EJ et al. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 1992; 267: 2215 20.en_US
dc.identifier.citedreferenceOesterling JE, Chute CG, Jacobsen SJ et al. Longitudinal changes in serum PSA (PSA velocity) in a community-based cohort of men. J Urol 1993; 149: 412A.en_US
dc.identifier.citedreferenceLilja H, Christensson A, Dahlen U et al. Prostate-specific antigen in human serum occurs predominantly in complex with alpha-1-antichymotrypsin. Clin Chem 1991; 37: 1618 25.en_US
dc.identifier.citedreferenceStenman UH, Leinonen J, Alfthan H, Rannikko S, Tuhkanen K, Alfthan O. A complex between prostate-specific antigen and alpha-1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer. Cancer Res 1991; 51: 222 6.en_US
dc.identifier.citedreferenceOesterling JE, Jacobsen SJ, Chute CG et al. Serum prostate-specific antigen in a community-based population of healthy men:establishment of age-specific reference ranges. JAMA 1993; 270: 860 4.en_US
dc.identifier.citedreferenceDalkin BL, Ahmann FR, Kopp JB. Prostate specific antigen levels in men older than 50 years without clinical evidence of prostatic carcinoma. J Urol 1993; 150: 1837 9.en_US
dc.identifier.citedreferenceCollins GN, Lee RJ, McKelvie GB, Rogers ACN, Hehir M. Relationship between prostate specific antigen, prostate volume, and age in the benign prostate. Br J Urol 1993; 71: 445 50.en_US
dc.identifier.citedreferenceChute CG, Panser LA, Girman CJ et al. The prevalence of prostatism:a population-based survey of urinary symptoms. J Urol 1993; 150: 85 9.en_US
dc.identifier.citedreferenceKlee GG, Dodge LA, Zincke H, Oesterling JE. Measurement of serum prostate specific antigen using IMx prostate specific antigen assay. J Urol 1994; 151: 94 8.en_US
dc.identifier.citedreferenceTerris MK, Stamey TA. Determination of prostate volume by transrectal ultrasound. J Urol 1991; 145: 984 7.en_US
dc.identifier.citedreferenceElveback LR, Guillier CL, Keating FR Jr. Health, normality, and the ghost of Gauss. JAMA 1970; 211: 69 78.en_US
dc.identifier.citedreferenceCooner WH. Early diagnosis of prostate cancer. In Walsh PC, Retik AB, Stamey TA, Vaughan Jr ED ( eds. ) Campbell's Urology, 6th edn, Update 4. Philadelphia: WB Saunders, 1993; 1 10.en_US
dc.identifier.citedreferenceJacobsen SJ, Klee GG, Lilja H, Wright GL Jr, Oesterling JE. Stability of serum prostate specific antigen across laboratory, assay, and storage time. J Urol 1994; in press.en_US
dc.identifier.citedreferenceBerry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984; 132: 474 9.en_US
dc.identifier.citedreferenceOesterling JE, Bilhartz DL, Tindall DJ. Clinically useful serum markers for adenocarcinoma of the prostate, II:prostate-specific antigen. Am Urol Assoc Update Ser 1991; 10: 137 44.en_US
dc.identifier.citedreferenceBreslow NC, Chan CW, Dhom G et al. Latent carcinoma of prostate at autopsy in seven areas. Collaborative study organized by the International Agency for Research on Cancer, Lyons, France. Int J Cancer 1977; 20: 680 8.en_US
dc.identifier.citedreferenceAkazaki K, Stemmermann GN. Comparative study of latent carcinoma of the prostate among Japanese in Japan and Hawaii. J Natl Cancer Inst 1973; 50: 1137 44.en_US
dc.identifier.citedreferenceMebane C, Gibbs T, Horm J. Current status of prostate cancer in North American black males. J Natl Med Assoc 1990; 82: 782 8.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1464-410X.1995.tb07347.x.pdf
Size:
653.8KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.